The Influence of Maggot Excretions on PAO1 Biofilm Formation on Different Biomaterials by unknown
ORIGINAL ARTICLE
The Influence of Maggot Excretions on PAO1 Biofilm Formation
on Different Biomaterials
Gwendolyn Cazander MD, Kiril E. B. van Veen,
Lee H. Bouwman MD, PhD, Alexandra T. Bernards MD, PhD,
Gerrolt N. Jukema MD, PhD
Received: 13 November 2007 / Accepted: 17 September 2008 / Published online: 16 October 2008
 The Association of Bone and Joint Surgeons 2008
Abstract Biofilm formation in wounds and on biomate-
rials is increasingly recognized as a problem. It therefore is
important to focus on new strategies for eradicating severe
biofilm-associated infections. The beneficial effects of
maggots (Lucilia sericata) in wounds have been known for
centuries. We hypothesized sterile maggot excretions and
secretions (ES) could prevent, inhibit, and break down
biofilms of Pseudomonas aeruginosa (PAO1) on different
biomaterials. Therefore, we investigated biofilm formation
on polyethylene, titanium, and stainless steel. Furthermore,
we compared the biofilm reduction capacity of Instar-1 and
Instar-3 maggot ES and tested the temperature tolerance of
ES. After biofilms formed in M63 nutrient medium on
comb-forming models of the biomaterials, ES solutions in
phosphate-buffered saline or M63 were added in different
concentrations. PAO1 biofilms adhered tightly to polyeth-
ylene and titanium but weakly to stainless steel. Maggot ES
prevent and inhibit PAO1 biofilm formation and even break
down existing biofilms. ES still had considerable biofilm
reduction properties after storage at room temperature for
1 month. ES from Instar-3 maggots were more effective
than ES from Instar-1 maggots. These results may be rele-
vant to patient care as biofilms complicate the treatment of
infections associated with orthopaedic implants.
Introduction
Biofilm formation (BF) on biomaterials is a major problem
in trauma and orthopaedic surgery [6]. Bacteria adhering to
prosthetic material can form a biofilm composed of a
complex extracellular polysaccharide matrix in which they
then become embedded [5]. The matrix prevents antibiotic
penetration and as a result protects bacteria against anti-
biotics [7, 28]. Once infected, the implant often must be
removed [18, 32]. Temporary implantation of antibiotic
beads is sometimes necessary [19].
The importance of BF was not acknowledged until
30 years ago, when the successful effects of penicillin and
other antibiotics were complicated by the increasing anti-
biotic resistance of bacteria [15]. In 1931, William Baer, an
orthopaedic surgeon at Johns Hopkins Hospital in Balti-
more, introduced maggot de´bridement therapy (MDT) [1]
around the same time Fleming discovered penicillin, but
MDT was supplanted because of the discovery of antibi-
otics [34]. Baer successfully used MDT for treatment of
children with severe osteomyelitis [1]. Interest in MDT for
wound healing was renewed in the 1980s [25], because the
antibiotic resistance of bacteria increased rapidly [26] and
antibiotic therapy and surgical treatment of wounds did not
suffice in some cases. Currently, maggots of Lucilia seri-
cata are widely used, have successful healing effects, and
were approved by the US Food and Drug Administration in
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2004 (510[k] #33391) [24, 27, 35]. Research to discover
the underlying mechanisms of action by which maggots
reduce bacterial infections could provide us with new
treatment possibilities for severe, infected wounds.
For certain wounds, we use sterile maggots captured in
small permeable bags, which consist of a 2- to 3-mm thin
foam layer of polyvinyl alcohol. These bags allow free
exchange of maggot excretions and secretions [11]. We
have observed resolution of infections suspected for bio-
film formation using maggots in bags. Therefore, we
suspected maggot excretions and secretions (ES) could
interfere with the biofilm in an infected wound and aid in
healing. If maggot ES can reduce biofilms, there may be
pharmacologic agents that could be developed from ES,
which could provide new treatment methods for biofilm-
associating infections.
We therefore asked whether (1) sterile maggot ES would
break down biofilms, prevent biofilm formation, and inhibit
further growth of existing biofilms; (2) the quantity of
biofilm formation of Pseudomonas aeruginosa depended on
the material surface (specifically, polyethylene, titanium,
or surgical stainless steel); (3) Instar-1 and Instar-3 maggot
ES comparably reduced biofilms; and (4) storage of ES
under different conditions and temperature reduced the
effects of ES on biofilms.
Materials and Methods
Biofilms were formed on comb-forming models of poly-
ethylene (PE), titanium (TI), and surgical stainless steel
(SSS) hanging in a 96-well microtiter plate with culture
medium and bacteria. Either ES were added directly to
the bacterial suspension to test biofilm prevention or ES
were added after 24 or 48 hours of BF to investigate
biofilm inhibition and/or breakdown. We used ES from
Instar-1 and Instar-3 maggots. Temperature tolerance was
tested by storing ES at -80C, at +4C, and at room
temperature for 1 day, 1 week, and 1 month before using
them.
We tested BF on comb-like devices consisting of eight
prongs (produced according to our design and requested
by Litos GmbH, Hamburg, Germany). The prongs were
made to fit into a flat-bottomed 96-well microtiter plate
(Greiner Bio-One, Alphen a/d Rijn, The Netherlands)
leaving 2 mm of free space at the sides and hanging 1 mm
from the bottom of the well (Fig. 1). Combs were made of
PE, TI, and SSS according to specifications for common
patient implants. All combs were sterilized by low-tem-
perature hydrogen peroxide gas plasma sterilization. We
considered each prong to be one test, and assays were
performed in at least quadruplicate. All controls were
made in octuplicate.
For our experiments, we chose P. aeruginosa strain
PAO1 because it is one of the major causes of orthopaedic
infections [8, 29] and it is able to form very stable biofilms
[20]. Bacteria (ATCC 15692) were grown overnight in
King’s medium B [14] at 28C under vigorous shaking
(190 rpm). We prepared a solution of a stationary phase
culture in phosphate-buffered saline (PBS) to a density of
McFarland 0.5 corresponding with 1.5 9 108 colony-
forming units (CFU) per milliliter. To determine the actual
inoculum, viable counts were made by inoculating nutrient
agar plates (Biome´rieux, Lyon, France) with 10-lL vol-
umes of serial 1:10 dilutions of the suspension. We
incubated the plates overnight at 37C and the colonies
were counted.
Biofilms were made in M63 nutrient medium, which
allows for BF as previously described by O’Toole and
Kolter [21]. We diluted the PAO1 suspension 1:30 in PBS
and then 1:20 in M63. A volume of 100 lL of the bacterial
suspension was added to 24 wells of a sterile 96-well flat-
bottomed microtiter plate. The final inoculum in each well
was 2.5 9 105 CFU/mL. We placed the combs in the wells
and incubated them for 24 hours at 37C, allowing for BF.
Control combs were placed in M63 medium. Microtiter
plates were covered using parafilm (Pechiney Plastic
Packaging, Chicago, IL).
After 24 hours, we washed each comb by placing it
under slow-running distilled tap water for 30 seconds. All
combs were placed in a new 96-well plate, dried in a
laminar flow cabinet for 5 minutes, and stained with 1%
crystal violet for 15 minutes (Fig. 2). Excess stain was
rinsed off by distilled water. After drying again in the flow
cabinet, we suspended each comb in a new column of wells
filled with 270 lL ethanol absolute to absorb the crystal
violet. To prevent evaporation of ethanol, plates were
sealed with adhesive coverslips (Nutacon BV, Leimuiden,
Fig. 1 Combs were made of TI (blue), PE (white), and SSS (silver)
hanging in a 96-well microtiter plate. TI = titanium; PE = polyeth-
ylene; SSS = surgical stainless steel.
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The Netherlands) and parafilm. We left the plates for 48
hours at room temperature to allow the biofilm to elute with
ethanol.
A volume of 150 lL of the ethanol solution was added
to a new plate and after brief, gentle shaking, the optical
density (OD) in the wells was read at a wavelength of
595 nm. The quantity of biofilm that is removed by elution
cannot be expressed in percentages; however, the combs of
TI and SSS seemed to be clean of CV after 48 hours of
elution. The stained biofilm on PE could not be eluted
entirely in ethanol (maximum time tested was 96 hours),
but we standardized the time of elution to 48 hours to
guarantee a reliable interpretation of the results. We tested
PAO1 BF on all materials in octuplicate.
Sterile Instar-1 (I1) and Instar-3 (I3) larvae were pro-
duced by BioMonde GmbH (Barsbu¨ttel, Germany). I1
maggots are freshly hatched from the egg and used after 24
hours when they measure 2 mm in length. I3 maggots are
full-grown larvae measuring 8 to 10 mm after living for 4
to 5 days. Sterile ES of Lucilia sericata were obtained by
incubating 400 I1 or 200 I3 larvae in a 100 lL 0.9% saline
solution in sterile tubes for 1 hour at 35C in darkness.
Before incubation, we washed the larvae twice in PBS.
After incubation, ES were removed by pipette, divided into
aliquots of 200 lL, and stored at -80C. One ES pool was
collected from at least 1000 maggots, which resulted in
approximately 1200 lL ES per hour. We used one aliquot
of the pool to determine the protein concentration using the
Pierce Bicinchonic Acid Protein Assay kit (Pierce Bio-
technology, Rockford, IL). The mean protein concentration
of the collected ES was approximately 1500 lg/mL (range,
1350–1700 lg/mL) and the pH was 8. We tested sterility of
ES in duplicate.
Three experiments were conducted on the biomaterials
to answer the first research question. We examined (1) the
influence of ES on an existing 24-hour biofilm to test the
breakdown of BF; (2) the influence of ES on BF during a
24-hour period to test the prevention of BF; and (3) the
influence of ES on further BF of an already formed 24-hour
biofilm to test inhibition and breakdown.
In Experiment 1, biofilms were allowed to grow on
seven combs of each of the materials for 24 hours. Then,
we rinsed the combs with distilled water and allowed them
to dry. Combs were dried to guarantee the exact protein
concentrations of ES in a well. One of the combs was used
as a negative control and suspended in a solution of PBS.
The remaining six combs were suspended in two ranges of
different dilutions of ES in PBS: a low concentration range,
which was 0.12, 0.37, 1.11, 3.33, 10, and 30 lg ES per
well, and a high concentration range, which was 20, 40, 60,
80, 100, and 120 lg ES per well. The volume added per
well was 25 lL higher (125 lL) than in the first 24-hour
BF. By achieving a slightly higher liquid level in the wells,
we made sure the 24-hour biofilm, which had been formed
on the air-liquid interface, was in contact with ES. All
wells were incubated for another 24 hours at 37C. Then
we quantified the biofilms as described previously.
In Experiment 2, 50 lL of serial dilutions of ES and
PBS was dissolved in 50 lL M63. We doubled the quantity
of nutrient ingredients in M63 to maintain the optimal
nutrient medium required for BF in a total volume of 100
lL. The low concentrations of ES were the same as de-
scribed in Experiment 1. The high range was different: 20,
30, 40, 50, 60, and 70 lg per well. This was caused by the
lower volume of ES dilutions. Sterile combs were sus-
pended in the solutions and incubated to determine a
possible inhibitory effect on BF. After 24 hours, we stained
biofilms on all prongs and measured them according to the
instructions described previously.
In Experiment 3 we repeated the method of Experiment
1; however, ES were now diluted in M63 instead of PBS to
allow further growth of the biofilm for an additional 24
hours. To investigate the influence of ES more precisely, a
more extensive range of low concentrations (2 to 24 lg ES
per well with intervals of 2 lg ES per well) was tested.
In Experiment 3, we compared all values with the results
of two controls: the 24-hour BF and the 48-hour BF. All
measurements lower than the 24-hour biofilm were defined
as a breakdown of existing biofilm caused by ES. Values
lower than the 48-hour biofilm and higher than the 24-hour
biofilm showed inhibition of BF. The total biofilm reduc-
tion was defined as the difference between the 48-hour
biofilm and the measurement (thus reduction means inhi-
bition and breakdown).
In every experiment, one pool of ES from I3 maggots
(ES I3) with equal concentrations of ES was used. We have
not compared the efficacy of ES in one experiment; how-
ever, ES were collected under strict, standard conditions by
Fig. 2 This illustration shows 24-hour biofilms formed by PAO1 on
all combs after staining with crystal violet.
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two of the investigators and we used only sterile ES, with
pH 8 and a protein concentration between 1350 and
1700 lg/mL.
For the second research question, we compared the OD
at 595 nm, which reflects the BF, among PE, TI, and SSS
after 24 hours incubation of the PAO1 suspension without
maggot ES.
To answer the third research question, we repeated
Experiment 3 with ES from I1 maggots (ES I1) in the low
concentration range to compare the effects on BF between
ES I1 and ES I3. It was not possible to test the high range,
because the quantity of ES that could be collected from I1
larvae was much lower than that from I3 larvae, although
the protein concentration was equal in both ES.
All figures on the influence of ES on BF were log-scaled
for better visualization and understanding in low and high
concentrations.
To answer the last research question, we investigated the
stability of the biofilm-influencing properties of maggot ES
under a range of different storage conditions. Therefore, we
used the method of Experiment 3 on TI combs. Nine 100-
lL aliquots of one batch of ES from I3 maggots were
collected. Three aliquots were stored at -80C, three at
+4C, and three at room temperature. One aliquot was
taken from each storage condition after 1 day, 1 week, and
1 month. Directly incubated ES from freshly delivered
maggots were tested as a control. We used a concentration
of 6 lg ES per well and all experiments were repeated 11
times.
The measured OD values of the biofilm experiments
were converted into percentages by using the following
formula:
ðOD ðbiofilmÞ  100%Þ=OD ðcontrolÞ
OD (biofilm) is the BF on the prongs tested with various
concentrations of ES. OD (control) is the BF after 24 hours
or 48 hours on the negative control prongs. In all
experiments, the 24-hour biofilm is considered 100% (in
Experiment 1, it is the 24-hour biofilm after 24 hours
incubation in PBS). Absolute OD values of the 24-hour
biofilms on all biomaterials are reported in Results. The
material-specific background absorbances were subtracted
from both OD values in this formula before using it.
For the first, third, and fourth research questions, we
used Student’s t-test for independent groups (Table 1). In
Experiments 1 and 2, for every concentration of ES sepa-
rately, we compared the mean BF with addition of ES and
Table 1. Overview of the study design
Research question Method Statistical analysis
(1) Do sterile maggot ES break
down, prevent, and/or inhibit
biofilms?
We conducted Experiment 1 to test the breakdown of
biofilms by ES: ES, diluted in PBS, were added to 24-
hour biofilms in different concentrations.
In Experiment 2, we tested prevention of BF by ES: ES,
diluted in PBS, were directly added to the nutrient
medium and bacteria.
Experiment 3 repeated the method of Experiment 1 but
ES were now diluted in nutrient medium to test
inhibition of further biofilm growth and breakdown of
existing biofilms.
All experiments were incubated during 24 hours and
done in quadruplicate.
Student’s t-test for independent variables
Experiments 1 and 2: A comparison was made
between the mean BF with ES (per
concentration) and the mean of the control BF
without ES.
Experiment 3: A comparison was made between
the mean BF with ES (per concentration) and
the mean of the 24-hour BF without ES. A
second comparison was made between the
mean BF with ES (per concentration) and the
mean of the 48-hour BF without ES.
(2) Does the quantity of biofilm
formation depend on the
material surface?
We allow 24-hour BF on comb-forming models of PE,
TI, and SSS. The experiment was done in octuplicate.
ANOVA: A comparison was made between the
quantities of biofilm on PE, TI, and SSS.
(3) Do Instar-1 and Instar-3
maggots comparably reduce
biofilms?
Experiment 3 was repeated with ES collected from
Instar-1 maggots to compare the effects of ES I1 and
ES I3 on biofilm inhibition and breakdown. The
experiment was done in quadruplicate.
Student’s t-test for independent variables
A comparison was made between the mean of
the BF with ES I1 and the mean of the BF with
ES I3 (per concentration).
(4) Does storage of ES under
different conditions and
temperature reduce the effects
of ES on biofilms?
We stored three aliquots of one pool ES at -80C, three
at +4C, and three at room temperature. Experiment
3 (only 6 lg ES per well) was conducted on TI after
1 day, 1 week, and 1 month and ES from every
storage condition was taken and biofilm inhibition
and breakdown was compared. This experiment was
done in 11-fold.
Student’s t-test for independent variables
A comparison was made between the mean BF
with ES for every storage condition and the
mean control BF without ES.
BF = biofilm formation; PE = polyethylene; TI = titanium; SSS = surgical stainless steel; ES = excretions and secretions; PBS = phosphate-
buffered saline; ES I1 = ES from Instar 1 maggots; ES I3 = ES from Instar 3 maggots; ANOVA = analysis of variance.
Volume 467, Number 2, February 2009 Maggot Excretions Reduce PAO1 Biofilms 539
123
the mean BF without addition of ES. In Experiment 3, the
mean BF of the samples with ES was compared with the
mean BF of controls after 24 hours and 48 hours. For the
third research question, we compared the mean BF with ES
I1 and the mean BF with ES I3 for each concentration
separately. The last research question was analyzed in the
same way as Experiment 3, comparing the mean BF with
ES for every storage condition with the mean control BF
without ES. For the second research question, we used one-
way ANOVA followed by the least significant difference
post hoc test to analyze if the quantity of BF depended on
the material surface. Therefore, we compared the quantity
of biofilm among PE, TI, and SSS. We performed all sta-
tistical analyses using SPSS1 for Windows1, Version 11.0
(SPSS Inc, Chicago, IL).
Results
Experiment 1 showed the addition of ES to existing bio-
films decreased these biofilms compared with biofilms
without addition of ES for TI and PE. In Experiment 1, the
breakdown (all p \ 0.001) on TI was maximal (58%) in the
range between 0.37 and 10 lg ES per well so there was less
biofilm compared with the control (Fig. 3A). For PE,
Experiment 1 showed a maximal breakdown (all
p \ 0.001) of 82% in the range between 1 and 10 lg ES
per well (Fig. 3B). BF for all concentrations was decreased
compared with the control. Prevention of biofilm was
tested in Experiment 2. BF was reduced (all p \ 0.001)
compared with control without ES on TI between 10 and
30 lg ES per well (Fig. 4A). On PE, BF was less (all
p B 0.013) for all concentrations between 0.37 and 30 lg
ES per well compared with the control BF (Fig. 4B).
Inhibition of further biofilm growth and breakdown by ES
was tested in Experiment 3. Addition of ES to existing
biofilms resulted in less BF compared with BF without
ES. ES further inhibited (all p B 0.038) biofilm on TI in
a concentration range between 2 and 18 lg ES per well to
a minimum of 47% of its original size (without ES)
(Fig. 5A). Experiment 3 also showed breakdown (all
p B 0.028) of biofilm on TI with a maximum of 53% in the
range between 2 and 6 lg ES per well (Fig. 5A). On PE,
the biofilm was inhibited to a minimum of 37% at con-
centrations of 20 and 22 lg ES per well (both p \ 0.001;
Fig. 5B). Less (all p B 0.018) BF with ES was seen for all
concentrations greater than 6 lg ES per well. Breakdown
of PE in Experiment 3 showed reduced (p \ 0.001 for both
concentrations) biofilm concentrations of 63% for 20 and
22 lg ES per well compared with the controls (Fig. 5B).
BF was greater on PE (OD595 0.381 after background
absorbances subtracted) than on TI (p \ 0.001; OD595
0.153) and SSS (p \ 0.001; OD595 0.051) (Fig. 6;
Table 2).
On TI, biofilm reduction was greater (p = 0.022) by ES
I3 than by ES I1 at 16 lg ES per well and all concentra-
tions higher (all p B 0.001) than 20 lg ES per well



























































Fig. 3A–B These figures show a comparison between the mean of
existing biofilms without addition of ES and with addition of ES and
answer partially the first research question, whether ES break down
biofilms. The control 48-hour biofilm is defined as 100% and all
values lower than this show breakdown of biofilm by ES. (A) Biofilm
was broken down (all p values \ 0.001) on TI by ES in a
concentration range from 0.37 to 80 lg ES per well. (B) Biofilm
was broken down (all p values \ 0.001) on PE by ES in a
concentration range from 0.12 to 10 lg ES per well. ES = excretions
and secretions; TI = titanium; PE = polyethylene.




























































Fig. 4A–B These figures show a comparison between the mean BF
with ES that were directly added to the bacteria and the mean control
24-hour BF without ES (defined as 100%) and answer partially the
first research question, whether ES prevent BF. All values lower than
100% show prevention of BF. (A) Biofilm was prevented (all p
values \ 0.001) on TI by ES in a concentration range from 10 to 30
lg ES per well. (B) Biofilm was prevented (all p values B 0.013) on
PE by ES in a concentration range from 0.12 to 30 lg ES per well.
BF = biofilm formation; ES = excretions and secretions; TI = tita-






























































Fig. 5A–B These figures show a comparison between the mean BF
with ES and the mean control 24-hour BF without ES (defined as
100%) and answer partially the first research question, whether ES
break down existing biofilms. All values lower than 100% show
breakdown of biofilm by ES. These figures also show a comparison
between the mean BF with ES and the mean control 48-hour
BF without ES (122% on TI and 163% on PE) and answer partially
the first research question, whether ES inhibit further biofilm growth.
All values lower than the 48-hour biofilm show inhibition of further
BF. (A) Biofilm was broken down (all p values B 0.028) on TI by
ES in a concentration range from 2 to 6 lg ES per well. Inhibition
(all p values B 0.038) occurred in a concentration range from 2 to 18
lg ES per well. (B) Biofilm was broken down (all p values B 0.011)
on PE by ES in a concentration range of 20 lg ES per well or
greater. Inhibition (all p values B 0.018) is observed in a concen-
tration range of 6 lg ES per well or greater. BFF = biofilm
formation; ES = excretions and secretions; TI = titanium; PE =
polyethylene.
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p B 0.039) by ES I3 than by ES I1, but in the concentration
range from 0.37 to 14 lg ES per well (Fig. 7B).
All stored ES inhibited biofilm (p = 0.010) compared
with the control; even ES stored at room temperature for
1 month showed 18% inhibition (Fig. 8). The ES with the
best biofilm reduction properties were directly used ES,
showing 45% inhibition (p \ 0.001) of biofilm compared
with control.
Discussion
BF on orthopaedic biomaterials causes severe infections
that are very difficult to treat and often lead to invalidating
consequences for patients [6, 19, 32]. Therefore, it is
important to investigate new treatment possibilities for
these kind of infections. In clinical practice, we observed
the successful effects of sterile maggots captured in per-
meable bags on severely infected wounds that were
suspected for BF and therefore, we hypothesized sterile
maggot ES would reduce BF. We also asked whether the
quantity of biofilms depended on the biomaterial surface,
whether ES from Instar-1 maggots and Instar-3 maggots
comparably reduced biofilms, and whether storage of ES
under different conditions and temperature decreased the
effects of ES on BF.
We note several limitations of our study. We tested only
the BF of P. aeruginosa. Although P. aeruginosa is not the
most common cause of infection, it is difficult to treat when
present. Moreover, P. aeruginosa (PAO1 strain) can form
strong biofilms in vitro and therefore is used as a model in
our experiments for 48 hours maximum [21]. However,
these biofilms will not be fully mature, but basic infor-
mation regarding influence of maggot ES against the P.
aeruginosa biofilm can be obtained [23]. We used the
crystal violet assay as a standard method to quantify bio-
films, but other methods could be used in vitro [36] and in
vivo [12]. We attempted to adapt our study conditions to
those in clinical practice by using biomaterials produced
according to specifications for common patient implants.
Our ES were collected under standard conditions in dark-
ness, had an acidity of pH 8, and were incubated at a
temperature of 35C. Therefore, we believe these results
are representative and that maggot ES have a strong
capacity to break down existing biofilms and inhibit their
formation.
Our findings suggest BF on TI and PE is successfully
prevented and inhibited by sterile maggot ES and biofilms
on both materials are broken down by ES. Furthermore, the
quantity of BF depends on the biomaterial surface and SSS
is the best biomaterial in its physiologic behavior with
respect to BF by P. aeruginosa. We found ES I3 are more
capable of reducing BF than ES I1 and sterile maggot ES
are still effective after storing it for 1 month at room
temperature.
The use of maggot therapy for wound de´bridement is an
ancient method that is widely used for treatment of acute
and chronic wound infections in trauma and orthopaedic
patients, although the exact mechanism of action of the
maggots in the healing process is unknown. Some clinical
reports document successful results of maggots in the
de´bridement, disinfection, and healing of many types of
severely infected wounds that failed to heal with conven-
tional treatment [11, 27, 30, 35]. Research of de´bridement
mechanisms underlying MDT show the production of
proteolytic and chymotrypsin-like enzymes in ES, which
could degrade extracellular matrix components in wounds
[3, 4, 33]. A more specific study reported the influence of
ES on the behavior of fibroblasts on extracellular matrix






















Fig. 6 The optical densities reflect the quantities of biofilms formed
in 24 hours on PE, TI, and SSS and answer the second research
question, whether BF depend on the material surface. PE has the
highest BF followed by TI and SSS with the weakest attachment to
biofilm. PE = polyethylene; TI = titanium; SSS = surgical stainless
steel; BF = biofilm formation.
Table 2. Optical density (595 nm) for a 24-hour biofilm and a









Polyethylene 0.381 0.620 0.0924
Titanium 0.153 0.187 0.0520
Surgical stainless steel 0.051 0.099 0.0371


























































Fig. 7A–B These figures show a
comparison between the mean of
the BF with ES I1 and the mean
of the BF with ES I3 and answer
the third research question,
whether ES I1 and ES I3 com-
parably reduce BF. The
comparison is made for every
concentration separately. (A)
The biofilm reduction on TI is
greater (all p values B 0.022)
with ES I3 than with ES I1 in a
concentration range of 20 lg ES
per well or greater. (B) The
biofilm reduction on PE is
greater (all p values B 0.039)
with ES I3 than with ES I1 in a
concentration range of 14 lg ES
per well or less. ES = excretions
and secretions; TI = titanium;
























































































Fig. 8 This figure shows the comparison between the mean of the
samples of BF with ES for every storage condition with the mean
control BF without ES and answers the fourth research question,
whether storage of ES under different conditions and temperatures
reduces the effects of ES on BF. Direct ES were immediately
incubated ES from freshly delivered I3 maggots. A concentration of
6 lg ES per well was used and added to an existing 24-hour biofilm
on TI (defined as 100%). All values lower than 100% show
breakdown of biofilm and all values lower than the 48-hour biofilm
without ES (118%) show inhibition of BF. All storage conditions
inhibit (for all conditions, p values B 0.010) BF. *These are the
storage conditions that showed a breakdown (for these conditions,
p values B 0.041) of biofilm. ES = excretions and secretions;
TI = titanium.
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fibroblasts on extracellular matrix, stimulate proliferation
and migration of fibroblasts, and therefore enhance tissue
formation and accelerate healing [10]. In another study, the
mechanical action of maggots has been suggested in aiding
tissue de´bridement [17]. One of the most intriguing
hypotheses regarding the effectiveness of maggots in
infected wounds is the idea that Lucilia sericata ES have
antibacterial properties. Several studies have reported in
vitro antibacterial activity, but not with consistent results.
Kerridge et al. performed a zone of inhibition assay and
found inhibition of bacterial growth by ES against Staph-
ylococcus aureus and P. aeruginosa [13]. Bexfield et al.,
who performed the same zone of inhibition assay, did not
find this inhibition or decrease in bacterial growth [2].
However, they found inhibition in the turbidimetric assay
and concluded the antibacterial activity depends on the
kind of experiment. The first report that described the
possible activity of ES against biofilms of P. aeruginosa
and S. aureus in in vitro experiments is the recently pub-
lished paper by van der Plas et al. [22].
Our results showed the physical properties of the bio-
materials influence the strength of BF. Given the very low
rate of BF, SSS seemed the best biomaterial in vitro. P.
aeruginosa biofilms attached strong to TI in our study,
according to Staphylococcus biofilms, as described by
Harris et al. [9]. Furthermore, in our study ES I3 resulted in
a greater reduction of the biofilm than ES I1, although the
protein concentration is equal in both ES. We presume the
composition of ES I1 differs from that of ES I3. I3 larvae
produce much more ES than I1 larvae. This may explain
why ES I3 are more effective in reducing biofilm. They
also would allow obtaining and preparing large quantities.
We have not tested the effectivity between the pools of ES
I3; however, we have a few points in which we can com-
pare the different pools. The 48-hour biofilm on TI, for
example, is approximately 122% in Experiments 5a and 7a
and 118% in Experiment 8. At 6 lg ES per well, the bio-
film on TI was reduced to 47% of its original size in
Experiments 5a and 7a and 64% in Experiment 8. We
expect the variability is not large because of the strict
conditions that were maintained during collection, as de-
scribed before.
Our temperature tolerance experiment shows in clinical
practice, we could store maggot ES at room temperature
for a few days without apparent loss of quality.
Protein concentrations of ES appeared optimal for bio-
film reduction in concentrations up to 10 to 20 lg ES per
well (80 to 160 lg ES/mL). van der Plas et al. also reported
biofilm reduction at concentrations up to 20 lg ES per well
[22]. In our in vitro experiments, each maggot produced
more than 1.8 lg ES per hour. If we assume the I3 larvae
have the same protein production every hour, it can be
derived that two maggots per square centimeter biofilm in
wounds during 24 hours are sufficient to reduce the biofilm.
This is much lower than the maggot quantities (from five to
ten larvae per square centimeter wound surface) that are
recommended for de´bridement [31]. Although still active,
higher concentrations provided less biofilm degradation. To
reduce BF on PE, higher concentrations of ES were needed
than on TI. This may be the result of the more porous
structure of PE, resulting in tighter adherence of biofilm.
There are a few possible explanations for the fact that the
efficacy of ES at higher concentrations (greater than 20 lg
ES per well) decreases. At higher enzyme concentrations,
acidity of the environment changes faster than at lower
concentrations and this change can play a role. We suggest a
cofactor needed to facilitate the process is depleted or an
enzyme with a negative allosteric effect is released. Another
explanation could be a covalent modification disturbs the
process and stops it or that membranes in the biofilm are
damaged and permeate an enzyme that inhibits the reduc-
tion [16]. Further research is needed to explore the
interaction of ES and BF.
We believe this work may be relevant to patient care,
because biofilms make treatment of infected orthopaedic
implants and prostheses more difficult [6, 19, 32]. For the
future, the influence of sterile ES on BF by different bac-
terial species on orthopaedic implants is our current topic
of research.
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